Arvinas, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its product candidates are ARV-110, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor (AR) protein for the treatment of men with metastatic castration-resistant prostate cancer, ARV-471, and ARV-766, a PROTAC protein degrader targeting the estrogen receptor protein for the treatment of patients with metastatic ER positive/HER2 negative breast cancer. The company was founded in February 2013 and is headquartered in New Haven, CT.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
246
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Arvinas Inc market cap is $423.03M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Arvinas Inc 52 week high is $14.51 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Arvinas Inc 52 week low is $6.33 as of November 22, 2026.
Arvinas Inc stock price today is $6.46.
Arvinas Inc stock price yesterday was $6.74.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Arvinas Inc's P/E ratio is -35.05.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Arvinas Inc P/B ratio is 0.8235.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Arvinas Inc 50-day moving average is $7.40.